Blog

India’s pharmaceutical sector is entering a defining phase in its evolution. For decades, the country has been recognised globally for its scale, reliability and quality

The Indian Pharmaceutical Market (IPM) is entering a transformative phase where traditional healthcare engagement models may no longer be sufficient to connect with the country’s

Spurred by the success of RevMed, numerous companies are now racing to develop similar drugs, dubbed “molecular glues”, which can be used to treat a

Researchers at the Indian Institute of Technology Madras (IIT Madras) have developed a patented, injectable hydrogel made from silk cocoons and seaweed that could transform

Solapur: Balaji Amines has successfully commissioned a Dimethyl Ether (DME) production plant at its Unit-4 project in Chincholi MIDC, Solapur, and commercial production commenced on

Sun Pharmaceutical Industries has struck its largest global deal to acquire US-based Organon for $11.75 billion. This deal expands Sun Pharma’s footprint to 150 markets.